Letter to the Editor

Page 6

Recently published articles about Letter to the Editor

PCC
Potential Use of Antidepressants for Long COVID
Letter to the Editor

May 16, 2024

The possibility of repurposing antidepressants as a potential treatment for long COVID first emerged following observations that antidepressants might reduce morbidity and mortality when administered during acute COVID.
, , , et al
PCC
Fentanyl Test Strips and Drug Use Modification
Letter to the Editor

May 14, 2024

The authors explore the use of fentanyl test strips as a harm reduction tactic to identify contaminated substances for people who use illicit drugs.
, ,
PCC
Do Not Overlook Bupropion Misuse
Letter to the Editor

April 30, 2024

Jasleen Kaur, MD, and colleagues comment on a case report published in the PCC.
, ,
JCP
Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?
Letter to the Editor

March 20, 2024

As choice of administration route is crucial during psychiatric emergencies, the authors stress the need for RCTs comparing onset of efficacy for agitation across different administration routes of the...
,
PCC
Letter to the Editor

March 3, 2024

Notice of retraction for a letter to the editor.
PCC
Drug Interactions Between Psychotropic Medications and Mpox Treatment
Letter to the Editor

February 15, 2024

The authors review pharmacologic interactions of Mpox treatments with psychotropic medications and antidepressants, antipsychotics, mood stabilizers, and sedatives.
, , , et al
PCC
Intravenous Ketamine vs Intranasal Esketamine for TRD
Letter to the Editor

February 13, 2024

Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.
, , , et al
PCC
Fentanyl-Laced Marijuana Use in Adolescents [Retracted]
Letter to the Editor

February 6, 2024

, , , et al
JCP
Reckoning Risk Retrospectively: Reply to Taipale et al
Letter to the Editor

January 22, 2024

In a reply to Taipale and colleagues, Dr Andrade discusses estimation of risk in case-control studies and in RCTs.
JCP
Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use
Letter to the Editor

January 22, 2024

The authors provide additional relative risk data in response to Dr Andrade’s comments on their study.
, , , et al
JCP
Testing for Sleep-Disordered Breathing in Psychiatric Practice
Letter to the Editor

January 10, 2024

Dr Barry Krakow comments on Benca and colleagues’ recent review of sleep apnea in psychiatric practice and calls for clinicians to screen for sleep-disordered breathing at intake.
PCC
Deprescribing Benzodiazepines: Is Harm Reduction Enough?
Letter to the Editor

December 28, 2023

Vania Modesto-Lowe, MD, MPH, and Claire N. Aurilio, BS, comment on a recent publication in the PCC.
,

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe